(Q45770002)

15 December 2017

title

Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis (English)

1 reference

15 December 2017

16

Takayuki Matsumoto

1 reference

15 December 2017

Shinji Tanaka

8

object named as

Shinji Tanaka

1 reference

15 December 2017

author name string

Yusuke Okuyama

1

1 reference

15 December 2017

Akira Andoh

2

1 reference

15 December 2017

Masakazu Nishishita

3

1 reference

15 December 2017

Ken Fukunaga

4

1 reference

15 December 2017

Koji Kamikozuru

5

1 reference

15 December 2017

Yoko Yokoyama

6

1 reference

15 December 2017

Yoshitaka Ueno

7

1 reference

15 December 2017

Hiroyuki Kuge

9

1 reference

15 December 2017

Syusaku Yoshikawa

10

1 reference

15 December 2017

Atsushi Sugahara

11

1 reference

15 December 2017

Emi Anami

12

1 reference

15 December 2017

Yoshinori Munetomo

13

1 reference

15 December 2017

Chiyuki Watanabe

14

1 reference

15 December 2017

Yoshihide Fujiyama

15

1 reference

15 December 2017

publication date

28 January 2013

1 reference

15 December 2017

Scandinavian Journal of Gastroenterology

published in

1 reference

15 December 2017

volume

48

1 reference

15 December 2017

issue

4

1 reference

15 December 2017

page(s)

412-418

1 reference

15 December 2017

Defects in mucosal immunity leading to ulcerative colitis

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Cortisone and corticotrophin in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Preliminary data on the use of apheresis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Clinical implications of mucosal healing for the management of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.763175

10.3109/00365521.2012.763175

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

release_whzmjo4glnapfiv5wcsv3zgsdu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/whzmjo4glnapfiv5wcsv3zgsdu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

15 December 2017